首页> 美国卫生研究院文献>Epidemiology and Infection >Prevalence of antibodies against rubella virus in The Netherlands 9 years after changing from selective to mass vaccination.
【2h】

Prevalence of antibodies against rubella virus in The Netherlands 9 years after changing from selective to mass vaccination.

机译:从选择性疫苗改为大规模疫苗接种后9年荷兰风疹病毒抗体的流行率。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A two-dose mass vaccination programme with a combined vaccine against measles, mumps and rubella (MMR) was adopted in the Netherlands in 1987, replacing the selective schoolgirl vaccination strategy introduced in 1974. To obtain insight into the effect of mass vaccination and the population's immunity, the antibody levels against rubella were studied in the general Dutch population and in religious groups refusing vaccination. In the national sample, we observed a high prevalence (96.5%) for rubella antibodies in vaccinated cohorts as well as in the older unvaccinated cohorts. No indications of rapidly waning immunity after vaccination were found. There are indications of low virus circulation in the last few years. The very high seroprevalence in women at childbearing age is consistent with the few reported cases of congenital rubella syndrome (CRS) at present. However, individuals in the age group of 1-9 years who are not vaccinated for religious or other reasons have a considerably lower seroprevalence and thus there is a potential risk of a CRS outbreak in the future.
机译:1987年在荷兰通过了两剂大规模疫苗接种计划,其中包括针对麻疹,腮腺炎和风疹的混合疫苗(MMR),取代了1974年引入的选择性女学生疫苗接种策略。为了深入了解大规模疫苗接种的效果和人口在荷兰的一般人群和拒绝接种疫苗的宗教团体中,都对免疫力,抗风疹的抗体水平进行了研究。在国家样本中,我们观察到在接种疫苗的人群以及较老的未接种疫苗的人群中风疹抗体的患病率很高(96.5%)。没有发现接种疫苗后免疫力迅速下降的迹象。有迹象表明,最近几年病毒传播率较低。育龄妇女的血清阳性率很高,与目前报道的先天性风疹综合症(CRS)病例一致。但是,由于宗教或其他原因未接种疫苗的1-9岁年龄组的血清阳性率较低,因此将来可能会爆发CRS。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号